In pancreatic cancer (PaCa), ELK1 has been found to regulate the expression of several genes contributing to tumor growth, invasiveness, metastasis, and chemoresistance. This evidence concerns the gene ELK1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.